tiprankstipranks
Zentek (ZTEK)
NASDAQ:ZTEK
Holding ZTEK?
Track your performance easily

Zentek (ZTEK) Stock Price & Analysis

54 Followers

ZTEK Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

5.19%1.01%93.79%
1.01% Other Institutional Investors
93.79% Public Companies and
Individual Investors

ZTEK FAQ

What was Zentek’s price range in the past 12 months?
Zentek lowest stock price was $0.50 and its highest was $1.48 in the past 12 months.
    What is Zentek’s market cap?
    Zentek’s market cap is $100.57M.
      When is Zentek’s upcoming earnings report date?
      Zentek’s upcoming earnings report date is Feb 07, 2025 which is in 17 days.
        How were Zentek’s earnings last quarter?
        Zentek released its earnings results on Nov 14, 2024. The company reported -$0.021 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.021.
          Is Zentek overvalued?
          According to Wall Street analysts Zentek’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Zentek pay dividends?
            Zentek does not currently pay dividends.
            What is Zentek’s EPS estimate?
            Zentek’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Zentek have?
            Zentek has 104,064,810 shares outstanding.
              What happened to Zentek’s price movement after its last earnings report?
              Zentek reported an EPS of -$0.021 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.105%.
                Which hedge fund is a major shareholder of Zentek?
                Currently, no hedge funds are holding shares in ZTEK
                ---

                Company Description

                Zentek

                Zentek is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?Zentek is?currently?focused on commercializing ZENGuard™, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases.?The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Zynex
                Zymeworks
                Astrotech
                Applied DNA Sciences
                Graphite One Resources
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis